C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study
Source: IPSOS Health Survey 2025 #HealthcareInnovation #DigitalHealth #PharmaTrends #HealthCommunication #GLP1 #HealthTech #PatientEngagement #DataDrivenInsights #LifeSciences #HealthMarketing #GlobalHealth #FutureOfHealthcare The GLP-1 market is hot and will get hotter
Our goal was to investigate the potential of a unique, selenium-containing parasite enzyme thioredoxin glutathione reductase (TGR) as a drug target
Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model
The therapeutic benefits of glutathione were enhanced when combined with a medically healthy diet and lifestyle improvements, accelerating the recovery process
A 503A pharmacy might assign a 14-day or 30-day BUD to their compounded semaglutide, not because the product fails after that period, but because their stability data only supports dating to that point